3 ms·
I'm not so much talking about "me too" specifically, that said, I don't feel that minor tweaks to process or formula are deserving of another patent and many ye
by tracker1 8y ago
I'm not so much talking about "me too" specifically, that said, I don't feel that minor tweaks to process or formula are deserving of another patent and many years of protections. And, as I said, I don't feel that there should be a single provider at all. The licensing for patents can be worked out, but imho if the sale of the drug required dual, independent sourcing as a requirement there would be at least some push downward on pricing.